D
Spyre Therapeutics, Inc. SYRE
$17.38 $0.603.58% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue 40.15M 41.62M 162.79M -- 32.64M
Gross Profit -40.15M -41.62M -162.79M -- -32.64M
SG&A Expenses 11.79M 11.94M 10.77M 10.65M 11.51M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 51.94M 53.57M 61.25M 55.39M 44.15M
Operating Income -51.94M -53.57M -61.25M -55.39M -44.15M
Income Before Tax -36.72M -44.79M -56.30M -69.01M -38.84M
Income Tax Expenses -- -15.00K 1.00K 18.00K --
Earnings from Continuing Operations -36.72M -44.77M -56.30M -69.03M -38.84M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -36.72M -44.77M -56.30M -69.03M -38.84M
EBIT -51.94M -53.57M -61.25M -55.39M -44.15M
EBITDA -- -- -61.07M -55.21M -43.96M
EPS Basic -0.49 -0.60 0.04 -1.36 -0.59
Normalized Basic EPS -0.48 -0.46 -0.64 -0.85 -0.54
EPS Diluted -0.49 -0.60 0.04 -1.36 -0.59
Normalized Diluted EPS -0.48 -0.46 -0.64 -0.85 -0.54
Average Basic Shares Outstanding 60.33M 60.27M 55.26M 50.89M 45.32M
Average Diluted Shares Outstanding 60.33M 60.27M 55.26M 50.89M 45.32M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --